Anthropic, the AI startup co-founded by former OpenAI researchers, is set to begin trading on November 19 following a $1.4 trillion valuation in one of the largest initial public offerings on record. The IPO marks a pivotal moment for investor sentiment toward AI amid rising Treasury yields, market turbulence, and recent leadership changes at major tech firms.
Anthropic’s IPO launch and market conditions
Anthropic’s shares are expected to debut on Thursday, November 19, with a target valuation of $1.3 trillion to $1.4 trillion, a reduction from earlier projections of up to $2 trillion. The company’s CEO, Dario Amodei, described AI’s potential to revolutionize fields such as healthcare and scientific research during a JPMorgan investor event, while emphasizing a cautious approach to the IPO process. Amodei stated that Anthropic aims to “underpromise and overdeliver” and is indifferent to the timing or market conditions of its public debut.
The IPO unfolds against a backdrop of increased market volatility, including a Microsoft Outlook outage that disrupted communications and a surge in Treasury yields, both of which have contributed to a cooling of investor enthusiasm for high-growth tech sectors. The offering follows the sudden ousting of Nvidia CEO Jensen Huang, whose company is both a major investor in and supplier to Anthropic. Nvidia’s stock volatility has added another layer of uncertainty to the IPO’s reception.
Anthropic’s origins and co-founder stakes
Anthropic was founded in 2021 by seven co-founders, including Dario Amodei and his sister Daniela Amodei, both former OpenAI executives. The team left OpenAI citing concerns over its commercialization focus and prioritization of AI safety. The co-founders collectively own about 10% of the company, with each holding approximately 240 million Class A shares. As of the most recent funding round, these shares were valued at $58.90 each, translating to roughly $14 billion per co-founder if the IPO reaches its target price of $70 to $78 per share.
The co-founders’ backgrounds span AI research, policy, and engineering, with key figures including Tom Brown (GPT-3 research lead), Jack Clark (policy director), and Jared Kaplan, Sam McCandlish, and Chris Olah (technical staff at OpenAI). Their stated mission was to shape AI development responsibly, a goal they pursued despite forgoing immediate commercial gains at OpenAI.
Corporate ambitions and investor caution
Amodei outlined a vision in which AI could render diseases like cancer and Alzheimer’s obsolete while unlocking new industries in robotics, cybersecurity, and scientific discovery. However, his measured tone contrasted with the lofty ambitions, reflecting broader investor skepticism about AI valuations. The IPO’s reduced valuation suggests a tempering of expectations, even as Anthropic positions itself as a leader in AI safety and frontier model development.
Wall Street’s marketing campaign for the IPO has mirrored this duality, emphasizing both transformative potential and prudent execution. The company’s approach contrasts with the hype surrounding past tech IPOs, signaling a shift toward more conservative valuation strategies in the AI sector.